Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: J Glob Antimicrob Resist. 2019 Mar 11;19:173–180. doi: 10.1016/j.jgar.2019.03.002

Figure 1.

Figure 1.

Distribution of antimicrobial resistance among CA-UTI E. coli isolates. Susceptible, isolates were susceptible to all agents tested; AMP-R, resistant to at least ampicillin for the ß-lactams tested; TET-R, tetracycline-resistant; SXT-R, trimethoprim/sulfamethoxazole-resistant; CAM-R, chloramphenicol-resistant; AMG-R, resistant to at least one tested aminoglycoside; FQ-R, resistant to at least one tested fluoroquinolone; NIT-R, resistant to nitrofurantoin. The figure inset displays the number and percent of isolates that are AMP-S (susceptible to all ß-lactams tested) and AMP-R.